Dosing of incretin pathway drugs
US12420014B2 · kind B2 · utility
0Cited by
4References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 4, 2024 |
| Grant date | Sep 23, 2025 |
| Priority date | — |
| Expiry date | Dec 4, 2044 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for administering a dosage of Cagrisema to a patient for the treatment of obesity, the method comprising: administering a dosage of Cagrisema to the patient, wherein the dosage of Cagrisema is determined by: receiving patient data relating to a patient, wherein the patient data includes patient weight data; and processing the patient data including the patient weight data with a dosage calculator to determine the dosage of Cagrisema for administering to the patient wherein the dosage calculator is derived from a pharmacokinetic, PK, model.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.